Long Elon, short Jensen: A research firm says retail traders are flocking back to Tesla and pivoting from Nvidia

Retail traders have been buying the year to date dip in Tesla shares, while buying of Nvidia stock has slowed, Vanda Research ...

It's not just Allbirds - another meme-stock season is on the horizon, Vanda Research says

U.S. tax season is over, but meme-stock season is just getting started. That is ​the view from Vanda Research, which tracks ...
Barchart on MSN

Vanda Research says retail investors are buying the Tesla stock dip. Should you?

Shares of Tesla (TSLA) have had a rough 2026 so far. TSLA stock is down 23% year-to-date (YTD), making it one of the worst ...

Vanda a new buy at B. Riley on 'historic discount'

B. Riley has initiated coverage of Vanda Pharmaceuticals (VNDA) at buy saying that the company is currently trading at a valuation that is a "historic discount" and is "untenable." The firm has a ...
Yahoo Finance

Vanda Pharmaceuticals Announces the Submission of an NDA to the FDA for Bysanti™ for the Treatments of Acute Bipolar I Disorder and Schizophrenia

WASHINGTON, March 31, 2025 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA) today announced that a New Drug Application (NDA) was submitted to the U.S. Food and Drug Administration ...
Benzinga.com

What's Going On With Vanda Pharmaceuticals Stock Wednesday?

Vanda said the FDA approved NEREUS (tradipitant), an oral neurokinin-1 (NK-1) receptor antagonist, for the prevention of vomiting induced by motion. The approval marks the first new pharmacologic ...